0000899243-19-022724.txt : 20190904 0000899243-19-022724.hdr.sgml : 20190904 20190904161446 ACCESSION NUMBER: 0000899243-19-022724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190830 FILED AS OF DATE: 20190904 DATE AS OF CHANGE: 20190904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VON RICKENBACH JOSEF H CENTRAL INDEX KEY: 0001007706 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 191074711 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION CITY: WALTHAM STATE: MA ZIP: 02451-1163 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-30 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001007706 VON RICKENBACH JOSEF H C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 210 WATERTOWN MA 02472 1 0 0 0 Common Stock 2019-08-30 4 P 0 15000 0.7312 A 68352 D Common Stock 2019-09-03 4 P 0 13466 0.7001 A 81818 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7155 per share to $0.75 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6805 per share to $0.7204 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Richard J. Wanstall, attorney-in-fact for Josef H. von Rickenbach 2019-09-04